Testosterone for Diabetes Mellitus (T4DM) Study with Dr. Abe Morgentaler

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

The T4DM study is the world's largest, randomized, controlled trial of testosterone therapy. The study found that testosterone treatment greatly reduced the number of men who progressed to real diabetes. There was also a percentage of men who started the study with diabetes and by the end of the study, were no longer diagnosable with having diabetes.

 

[madman]

Testosterone for prevention and reversal of diabetes in men with low T

Abstract Men with obesity and/or type 2 diabetes (T2D) have a high prevalence of testosterone deficiency (TD). Similarly, men with TD has an increased risk of developing obesity and/or T2D, and further body fat accumulation and deterioration of glycemic control create a vicious cycle. The...

www.excelmale.com

Testosterone therapy and diabetes

https://www.nebido.com/hcp/testosterone-resources/congress-videos/essm-2021-symposium/essm-2021-symposium-sa-abraham-morgentaler Sexual medicine perspective on recent evidence regarding testosterone therapy and diabetes (2021) Speakers Abraham Morgentaler, MD, FACS President, Androgen...

www.excelmale.com

Androgen Society 3rd Annual Meeting Review (Day 2)

Androgen Society 3rd Annual Meeting Review (Day 2) – Summary: Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews the second day of the 3rd annual meeting of the Androgen Society, an international organization consisting of healthcare...

www.excelmale.com

Benefits of treating men with hypogonadism and prediabetes/diabetes

https://www.nebido.com/hcp/testosterone-resources/congress-videos/essm-2021-symposium/essm-2021-symposium-sa Benefits of treating men with hypogonadism and prediabetes/diabetes (2021) Speakers Prof. Dr. Michael Zitzmann Fellow of the Royal Society of Medicine Andrologist, Endocrinologist...

www.excelmale.com

SHBG: biomarker and hepatokine?

Over the past decade, there have been important breakthroughs in our understanding of the regulation and function of sex hormone-binding globulin (SHBG). A recent genome-wide association and Mendelian randomization study have provided new insights at the population level. A thorough study of...

www.excelmale.com

Testosterone and Diabetes: Interview with Paresh Dandona

www.excelmale.com

Low Testosterone in Men: Recommendations on the diagnosis, treatment and monitoring

ABSTRACT The relative proportional increase of the elderly population within many countries will become one of the most significant social transformations of the twenty-first century and, for the first time in history, persons aged 65 or above outnumbered children under five years of age...

www.excelmale.com

Diabetes Mellitus Causes Male Reproductive Dysfunction

Abstract The metabolic disorders caused by diabetes can lead to various complications, including dysfunction of the male reproductive system. In patients with diabetes, long-term hyperglycemia results in diabetic vascular neuropathy, oxidative stress injury, abnormal zinc metabolism, and...

www.excelmale.com

Diabetes and Sexuality

This ISSM Webinar will be about Diabetes and Sexuality. Medical comorbidities often have a significant impact on sexuality either directly or indirectly secondary to medical interventions. In addition to the physical aspects, chronic illness can also lead to significant psychological burdens...

www.excelmale.com

Testosterone and Diabetes (Risk/Prevention)

Testosterone, Diabetes Risk, and Diabetes Prevention in Men (2022) Bu B. Yeap, MBBS, Ph.D. *, Gary A. Wittert, MBBCh, MD INTRODUCTION Obesity is increasingly prevalent in developed and developing countries and contributes to increasing rates of type 2 diabetes (T2D) globally.1,2 In addition...

www.excelmale.com

Diabetes and Microvascular Complications

Diabetes-Related Microvascular Complications – A Practical Approach (2022) Basem M. Mishriky, MD, Doyle M. Cummings, Pharm, FCP, FCCP, James R. Powell, MD DIABETIC SYMMETRIC POLYNEUROPATHY What is Diabetic Symmetric Polyneuropathy? Diabetic neuropathy is classified into diffuse neuropathy...

www.excelmale.com

SHBG as a novel therapeutic target in the treatment of MetS and NAFLD

Sex hormone-binding globulin as a potential drug candidate for liver-related metabolic disorders treatment (2022) Nabila Bourebaba, ThuHa Ngo, Agnieszka Smieszek, Lynda Bourebaba, Krzysztof Marycz ABSTRACT Sex hormone-binding globulin (SHBG) is a hepatokine that binds to circulating steroid...

www.excelmale.com

Obesity, type 2 diabetes, and testosterone in aging men

www.excelmale.com

Management of ED in men with diabetes mellitus unresponsive to PDE5i

ABSTRACT Introduction. Erectile dysfunction (ED) is associated with diabetes mellitus with an estimated prevalence of 52.5% in the diabetic population. The first-line therapy for ED is phosphodiesterase type 5 inhibitors (PDE5i), but data suggest that diabetic men may be less responsive than...

www.excelmale.com

40% of men with type 2 diabetes have symptomatic testosterone deficiency

On-Demand webinar: 40% of men with type 2 diabetes have symptomatic testosterone deficiency – why are we still not finding and treating these men? https://abcd.care/resource/demand-webinar-40-men-type-2-diabetes-have-symptomatic-testosterone-deficiency-%E2%80%93-why-are-we In the fourth of our...

www.excelmale.com

Effects of testosterone therapy in adult males with hypogonadism and T2DM

Effects of testosterone therapy in adult males with hypogonadism and T2DM: A meta-analysis and systematic review (2022) Satesh Kumar, Mahima Khatri, Rahat Ahmed Memon, Jordan Llerena Velastegui, Kristina Zumbana Podaneva, Daniela Benitez Gutierrez, Bilawal Nadeem, Akhil Raj Anumolu, Masood...

www.excelmale.com

 

[madman]

Dandona Honored For Study of Hypogonadism and its Treatment With Testosterone

Paresh Dandona, MD, PhD, has been honored with a Lifetime Achievement Award from the Androgen Society for recognition of his continuing and progressive contributions to the study of hypogonadotropic hypogonadism and its treatment with testosterone, which led to several novel discoveries.

medicine.buffalo.edu

 

[madman]

Testosterone replacement in men with T2DM lowers HbA1c: ABCD worldwide audit

At EASD 2023 in Hamburg, Professor Hugh Jones presents an analysis from the ABCD audit of Testosterone in Men with Type 2 Diabetes, confirming that testosterone replacement therapy does improve glycaemic control. Furthermore, the data showed that HbA1c continues to decrease over time. This was...

www.excelmale.com